What is it about?
Thanks to recent advances in novel therapeutic options, the prognosis of ATC patients appears to be improving year by year. This review focuses on current evidence and future perspectives of anticancer drug therapy for ATC.
Featured Image
Photo by Sangharsh Lohakare on Unsplash
Why is it important?
ATC is one of the rarest and most aggressive malignancies and its prognosis remains dismal. Nevertheless, many clinical trials for ATC are ongoing and treatment outcomes are gradually improving year by year. This review article helps understanding the current status and future pserspectives of systmeic therapy for ATC.
Perspectives
Most clinical trials, to date, have been small, however, with fewer than 100 patients. Further efforts to develop novel treatments for this malignancy await the development of substantial infrastructure for international collaborative investigation.
Naomi Kiyota
Kobe University Hospital
Read the Original
This page is a summary of: Anticancer drug therapy for anaplastic thyroid cancer, European Thyroid Journal, March 2025, Bioscientifica,
DOI: 10.1530/etj-24-0287.
You can read the full text:
Contributors
The following have contributed to this page
